Integrative Molecular Analyses of an Individual Transcription Factor-Based Genomic Model for Lung Cancer Prognosis

Abstract

The proposed TF genomic model acts as a promising marker for estimation of lung cancer patients' outcomes. Prospective research is required for testing the clinical utility of the model in individualized management of lung cancer.